Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bezwada Biomedical
AddedFeb 18, 2024
UpdatedJun 18, 2026
Bezwada Biomedical

Bezwada Biomedical

Bezwada Biomedical: US-based specialists in biomedical absorbable polymers.

HQ
Hillsborough Township, NJ, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Founded in Somerset, United States, Bezwada Biomedical focuses on the development and commercialization of biomedical absorbable polymers. Their core mission is to innovate and provide advanced materials for medical devices, drug delivery systems, and regenerative medicine. The company offers a range of products including bioinks for 3D printing, PEG acrylates/methacrylates, PLGA bioinks, absorbable polyurethanes, and polyoxaesters. Their market focus includes medical device manufacturers, pharmaceutical companies, and research institutions.

Bezwada Biomedical has received notable recognition, including an NSF SBIR Phase II Award for their work on bioabsorbable tissue adhesives. The company is affiliated with experts in polymer science and biomedical engineering, contributing to its innovative edge. Their key achievements include the development of specialty absorbable polymers that go beyond traditional PLGA, offering tunable properties for various medical applications. Overall, Bezwada Biomedical has significantly impacted the field of biomedical materials by advancing the capabilities and applications of absorbable polymers.

Bezwada Biomedical - Similar Companies

ZWI Therapeutics logo

ZWI Therapeutics

zwitx.com

Bioabsorbable Therapeutics logo

Bioabsorbable Therapeutics

RevBio logo

RevBio

Endomedix logo

Endomedix

endomedix.com

Glycologix logo

Glycologix

glycologix.com

Danimer Scientific logo

Danimer Scientific

danimer.com

BioHybrid Solutions logo

BioHybrid Solutions

Adient Medical logo

Adient Medical

adientmedical.com

Biomimedica logo

Biomimedica

biomimedica.com

Flex Biomedical logo

Flex Biomedical

flexbio.com

Pegasus Biologics logo

Pegasus Biologics

pegasusbio.com

BioPoly logo

BioPoly

biopolyortho.com

BioSurfaces logo

BioSurfaces

biosurfaces.us

Imbed Biosciences logo

Imbed Biosciences

imbedbio.com

New Ortho Polymers logo

New Ortho Polymers

Bezwada Biomedical - Quick Facts

Who are Bezwada Biomedical's competitors?

Companies similar to Bezwada Biomedical include ZWI Therapeutics, Bioabsorbable Therapeutics, RevBio and Endomedix.

When was Bezwada Biomedical founded?

Bezwada Biomedical was founded in 2003.

Where is Bezwada Biomedical's headquarters located?

Bezwada Biomedical's headquarters is located in Hillsborough Township, NJ, US.

When was Bezwada Biomedical's last funding round?

Bezwada Biomedical's most recent funding round was for $50k (USD) in February 2023.

How much has Bezwada Biomedical raised to-date?

As of Feb 16, 2023, Bezwada Biomedical has raised a total of $275k (USD).

How many employees does Bezwada Biomedical have?

Bezwada Biomedical has 8 employees as of Feb 4, 2024.

Bezwada Biomedical - Classification

Ownership
  • Private
Technology
  • Polymers
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Software
Customer
  • Enterprise
Main Product
  • Biomedical Polymers
Tags
  • Biotech
  • Materials
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations